Pramipexole dihydrochloride
- Product NDC
- 33342-032
- 11-digit product format
- 333420032
- Labeler code
- 33342
- Product ID
- 33342-032_721c81fc-fd21-4d86-ab96-9a329b8e015b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pramipexole dihydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Macleods Pharmaceuticals Limited
- Application
- ANDA202164
- Marketing category
- ANDA
- Marketing start
- 2012-09-21
- Substance
- PRAMIPEXOLE DIHYDROCHLORIDE
- Active strength
- .25 mg/1
- Pharmacologic classes
- Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33342-032-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33342-032-06 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33342-032-10 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 33342-032-15 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33342-032-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33342-032-06 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33342-032-10 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 33342-032-15 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33342-032-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33342-032-06 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33342-032-10 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 33342-032-15 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33342-032-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33342-032-06 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33342-032-10 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 33342-032-15 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33342-032-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33342-032-06 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33342-032-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 33342-032-15 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 33342-032-12 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 33342-032-06 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 33342-032-10 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 33342-032-15 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 33342-032-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 33342-032-06 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 33342-032-10 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 33342-032-15 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 33342-032-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 33342-032-06 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 33342-032-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 33342-032-15 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 33342-032-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 33342-032-06 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 33342-032-10 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 33342-032-15 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 33342-032-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 33342-032-06 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 33342-032-10 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 33342-032-15 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 33342-032-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 33342-032-06 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 33342-032-10 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 33342-032-15 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | ||
| A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | ||
| A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | ||
| A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | ||
| A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202164-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | 2012-09-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202164-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | 2012-09-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202164-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | 2012-09-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202164-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | 2012-09-20 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202164-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | 2012-09-20 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A202164-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202164-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202164-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202164-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202164-005 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A202164-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202164-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202164-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202164-004 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202164-005 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A202164-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202164-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202164-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202164-004 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202164-005 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A202164-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202164-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202164-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202164-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202164-005 | AB | 1 | ea99ee380514… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pramipexole dihydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PRAMIPEXOLE DIHYDROCHLORIDE | .25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3D867NP06J | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b8c94917-73a1-44c2-8fd8-07f45054176b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a67b8488-0225-64b1-be81-5cbe60d285a5 | Product name | 9 | 20221116 |
| 3863aae0-7028-3427-389e-3f6c8692e587 | Product name | 3 | 20190117 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33342-032-06 | Pramipexole dihydrochloride | 30 in 1 CARTON | TABLET | 30 | 10 | |
| 33342-032-06 | Pramipexole dihydrochloride | 1 in 1 BLISTER PACK | TABLET | 1 | 10 | |
| 33342-032-10 | Pramipexole dihydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 10 | |
| 33342-032-12 | Pramipexole dihydrochloride | 1 in 1 BLISTER PACK | TABLET | 1 | 10 | |
| 33342-032-12 | Pramipexole dihydrochloride | 100 in 1 CARTON | TABLET | 100 | 10 | |
| 33342-032-15 | Pramipexole dihydrochloride | 500 in 1 BOTTLE | TABLET | 500 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33342-032-10 | EA - Each | 33342-032 | 13f089fd-8583-47cf-8637-ea6eefa83715 | 1 | 2013-08-02 |
| 33342-032-15 | EA - Each | 33342-032 | 57abf334-8b0b-469c-be6d-56418ea56abf | 1 | 2015-06-09 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PRAMIPEXOLE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3D867NP06J | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 4 | |
| PRAMIPEXOLE | ACTIVE MOIETY | 83619PEU5T | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 4 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 4 | |
| POVIDONE K25 | INACTIVE INGREDIENT | K0KQV10C35 | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 4 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pramipexole dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Macleods Pharmaceuticals Limited | b8c94917-73a1-44c2-8fd8-07f45054176b | 2025-10-15 | Warnings, Adverse reactions | 202164 ANDA202164 33342-032 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 859033 | pramipexole dihydrochloride 0.125 MG Oral Tablet | PSN | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859040 | pramipexole dihydrochloride 0.25 MG Oral Tablet | PSN | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859044 | pramipexole dihydrochloride 0.5 MG Oral Tablet | PSN | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859052 | pramipexole dihydrochloride 1 MG Oral Tablet | PSN | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859048 | pramipexole dihydrochloride 1.5 MG Oral Tablet | PSN | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859033 | pramipexole dihydrochloride 0.125 MG Oral Tablet | SCD | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859040 | pramipexole dihydrochloride 0.25 MG Oral Tablet | SCD | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859044 | pramipexole dihydrochloride 0.5 MG Oral Tablet | SCD | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859052 | pramipexole dihydrochloride 1 MG Oral Tablet | SCD | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859048 | pramipexole dihydrochloride 1.5 MG Oral Tablet | SCD | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859033 | pramipexole dihydrochloride 0.125 MG (pramipexole 0.088 MG) Oral Tablet | SY | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859040 | pramipexole dihydrochloride 0.25 MG (pramipexole 0.18 MG) Oral Tablet | SY | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859044 | pramipexole dihydrochloride 0.5 MG (pramipexole 0.35 MG) Oral Tablet | SY | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859052 | pramipexole dihydrochloride 1 MG (pramipexole 0.7 MG) Oral Tablet | SY | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
| 859048 | pramipexole dihydrochloride 1.5 MG (equivalent to pramipexole 1 MG) Oral Tablet | SY | b8c94917-73a1-44c2-8fd8-07f45054176b | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 33342-032-06 | 33342003206 | 30 BLISTER PACK in 1 CARTON (33342-032-06) / 1 TABLET in 1 BLISTER PACK | 30 blister pack | 2012-09-21 | No | No | Current |
| 33342-032-10 | 33342003210 | 90 TABLET in 1 BOTTLE (33342-032-10) | 90 tablet | 2012-09-21 | No | No | Current |
| 33342-032-12 | 33342003212 | 100 BLISTER PACK in 1 CARTON (33342-032-12) / 1 TABLET in 1 BLISTER PACK | 100 blister pack | 2012-09-21 | No | No | Current |
| 33342-032-15 | 33342003215 | 500 TABLET in 1 BOTTLE (33342-032-15) | 500 tablet | 2012-09-21 | No | No | Current |